Table 2.

Selective Serotonin Reuptake Inhibitor and Serotonin Norepinephrine Reuptake Inhibitor Antidepressant Options

MedicationAnziolytic Efficacy*AdvantagesDisadvantages
FluoxetinePanic,† PTSD*Generic available; long half life (no withdrawal)Most stimulating; longer half life
ParoxetinePanic,† GAD,† SAD,† PTSD†Generic available; most extensively studied across these anxiety disorders; least stimulating; no P450 3A4 effectsMost sedating; shorter half life and worse withdrawal
SertralinePanic,† GAD,* SAD,† PTSD†Well-studied across these 4 anxiety disorders; least P4502D6 effects; minimal P4503A4 effects; intermediate half life (less withdrawal)Most diarrhea
CitalopramPanic*Generic available; no P450 effects
EscitalopramPanic,* GAD,† SAD*No P450 effects
Venlafaxine ERPanic,† GAD,† SAD,† PTSDNo P450 effects, pain effectsShort half life; withdrawal with missed dose or sudden discontinuation; increased blood pressure at >225 mg
DuloxetineGAD†Pain effectsUnclear efficacy for other anxiety disorders; more stimulating
  • ↵* Randomized controlled trials but no Food and Drug Administration-approved indication.

  • ↵† Food and Drug Administration-approved indication as of January 2006.

  • GAD, generalized anxiety disorder; PTSD, posttraumatic stress disorder; SAD, social anxiety disorder.